Last updated: March 1, 2026
What is NDC 83324-0053?
NDC 83324-0053 refers to a specific drug product listed in the National Drug Code directory. It corresponds to [drug name, dosage, form, and manufacturer details if available; if unknown, this needs to be confirmed from authoritative sources like FDA or commercial databases]. The drug's primary indication, route of administration, and licensing status influence its market and pricing.
Market Overview
Therapeutic Category and Indications
The categorization and approved indications determine the competitive landscape. For NDC 83324-0053, what is known about its therapeutic class? It is crucial to examine:
- The volume of existing competitors in its class
- The prevalence of the condition it treats
- Off-label uses that may expand its utilization
Market Size and Demand
Estimates based on disease prevalence, diagnosis rates, and current prescription patterns.
| Parameter |
Value |
Source |
| Estimated patient population |
X million |
[1] |
| Current annual prescriptions |
Y million units |
IMS Health (IQVIA) [2] |
| Growth rate (past 3 years) |
Z% |
Market research reports |
Note: Data points are placeholders. Precise figures depend on latest reports.
Competitor Landscape
Top competitors include:
- Brand drugs with similar indications
- Biosimilars if applicable
- Off-label competitors
Market share distribution varies. For example, the leading brand captures approximately X% of prescriptions, with biosimilars holding Y%.
Pricing Trends and Reimbursement
Pricing depends on:
- Wholesale Acquisition Cost (WAC)
- Average Selling Price (ASP)
- Reimbursement policies by Medicare, Medicaid, and private insurers
Average WAC for comparable drugs ranges between $X–$Y per unit, with variations based on formulation and dosage.
Price Projections
Short-term Forecast (Next 12 Months)
Assuming regulatory stability and no major market disruptions, price adjustments typically align with inflation, supply chain factors, or changes in reimbursement policies.
| Scenario |
Price Change |
Rationale |
Expected Price Range (per unit) |
| Base Case |
0% |
No major market shifts |
$X–$Y |
| Increased Competition |
-10% to -15% |
Entry of biosimilars or generics |
$X'–$Y' |
| Supply Constraints / Shortage |
+10% to +20% |
Supply chain disruptions |
$X''–$Y'' |
Long-term Forecast (Next 3–5 Years)
Price trajectories depend on patent status, generic entry, and market expansion. Historical data show:
- Post patent expiry, prices can decline 30-50% within 2–3 years
- Branding initiatives and new indications may sustain premium pricing
Assuming patent exclusivity continues, a compound annual growth rate (CAGR) of 2–4% is typical. Once patent expires, prices tend to decline by 15–20% per year until stabilization.
Key Influencing Factors
- Patent status: patent expiry date influences generic entry.
- Market penetration: increased adoption can support premium pricing.
- Regulatory changes: modifications in approval or reimbursement can alter prices.
- Manufacturing costs: impact on WAC and ASP.
Regulatory and Policy Environment
- As of 2023, no major regulatory changes affecting pricing or approval status have been announced.
- The Inflation Reduction Act may influence drug pricing negotiations under Medicare.
Conclusion
NDC 83324-0053 exists within a competitive framework heavily influenced by patent and market dynamics. Prices will likely remain stable or decline gradually unless disrupted by biosimilar entry or regulatory actions.
Key Takeaways
- Accurate market size estimates require current prescription data.
- Price projections vary based on patent status, market competition, and policy.
- Short-term prices are expected to stay stable; long-term trends predict gradual declines post-patent expiry.
- Competitive pressures are increasing, particularly from biosimilar entrants.
- Policy developments may alter reimbursement and pricing strategies.
FAQs
- What factors most impact the price of NDC 83324-0053? Patent status, competition, and reimbursement policies primarily influence pricing.
- When is patent expiry expected? This information depends on the patent filing and approval dates, typically available from FDA records.
- Are biosimilars a threat to this drug’s pricing? Yes; biosimilar entry generally leads to price reductions.
- How do regulatory changes affect future prices? Approval or policy shifts can influence reimbursement and market access, subsequently impacting pricing.
- What data sources are best for tracking actual prices? IMS Health (IQVIA), Medicare Part D formularies, and wholesale distributors provide updated pricing data.
References
[1] U.S. Census Bureau. (2022). National population estimates.
[2] IQVIA Institute. (2022). The Impact of Biosimilars on the U.S. Market.
